LONDON, UK: Sproutly Canada and Apollon Formularies have announced the completion of their due diligence. Sproutly, a Canadian company that specializes in natural cannabinoids, terpenes, and mushroom compounds, is poised to acquire all global assets of Apollon, a UK-based company that focuses on natural biologics drug discovery, integrating cutting-edge artificial intelligence (AI) technology. The transaction,…
All posts tagged Apollon Formularies
Apollon Formularies to join US OTC Market and migrate to larger exchange
LONDON, UK: Apollon Formularies plc (AQSE: APOL), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, is advancing an application to join the OTCQB Market (“OTCQB”) in the United States. Apollon’s Ordinary Shares will continue to trade on the Aquis Stock Exchange under the symbol APOL. The Company decided to undertake this…